English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The preponderance of scientific evidence suggests that monitoring and control of blood glucose prevents vascular complications of diabetes and, consequently, long-term medical costs associated with diabetes. While this effect is widely believed to apply to long-term rather than nearterm costs, Sokol and colleagues reported that better medication adherence in diabetes may result in an annual near-term cost reduction of $4,297 per person. This methodology was used by the California Public Employees Retirement System to report that people with diabetes were noncompliant with care incurred $3,384 more in medical costs per year than those who were at least partially compliant.

Deployment of an mHealth Patient Monitoring Solution for Diabetes—Improved Glucose Monitoring Leads to Reduction in Medical Expenditure